Post <scp>COVID</scp>‐19 syndrome with impairment of <scp>flow‐mediated</scp> epicardial vasodilation and flow reserve

Abstract

Post-acute sequelae of COVID-19 cardiovascular syndrome may be associated with an impairment of flow-mediated epicardial vasodilation, while reductions in coronary vasodilator capacity appear predominantly related to increases in resting flow in women deserving further investigations.